Medical term:

daclizumab



daclizumab

 [dah-kliz´u-mab]
an immunosuppressant used to prevent acute organ rejection in renal transplant patients; administered intravenously.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

daclizumab

Dacliximab, Zenapax® Transplant medicine A monoclonal antibody used with other agents to ↓ transplant-related GVHD and organ rejection in kidney and liver graft recipients, and Pts with treatment refractory psoriasis, uveitis, tropical spastic paraparesis and some leukemias. See Kidney transplant.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

daclizumab

A humanized monoclonal antibody against the interleukin-2 receptor. It is used to decrease the risk of organ rejection in kidney and heart transplants.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005


Latest Searches:
Whitman - whitlow - whitlockite - Whitfield - whitewater - Whiteside - whitepox - whiteleg - whiteheads - whitehead - whitegraft - whitecomb - White - whistling - whistle - whispering - whispered - whisper - whirlpool - whirling -
- Service manuals - MBI Corp